JP2017503846A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2017503846A5 JP2017503846A5 JP2016548186A JP2016548186A JP2017503846A5 JP 2017503846 A5 JP2017503846 A5 JP 2017503846A5 JP 2016548186 A JP2016548186 A JP 2016548186A JP 2016548186 A JP2016548186 A JP 2016548186A JP 2017503846 A5 JP2017503846 A5 JP 2017503846A5
- Authority
- JP
- Japan
- Prior art keywords
- dose
- patient
- treatment
- use according
- delivered
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AU2014900232 | 2014-01-24 | ||
| AU2014900232A AU2014900232A0 (en) | 2014-01-24 | Treatment of Neoplasia | |
| PCT/AU2015/000037 WO2015109367A1 (en) | 2014-01-24 | 2015-01-23 | Treatment of neoplasia |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2017503846A JP2017503846A (ja) | 2017-02-02 |
| JP2017503846A5 true JP2017503846A5 (enExample) | 2018-02-22 |
Family
ID=53680513
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016548186A Pending JP2017503846A (ja) | 2014-01-24 | 2015-01-23 | 新生物の治療 |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US10849900B2 (enExample) |
| EP (1) | EP3096752A4 (enExample) |
| JP (1) | JP2017503846A (enExample) |
| KR (1) | KR102317751B1 (enExample) |
| CN (1) | CN106102735A (enExample) |
| AU (1) | AU2015208666B2 (enExample) |
| BR (1) | BR112016016932A8 (enExample) |
| CA (1) | CA2937015C (enExample) |
| IL (1) | IL246880B (enExample) |
| PH (1) | PH12016501407A1 (enExample) |
| SG (1) | SG11201605900VA (enExample) |
| WO (1) | WO2015109367A1 (enExample) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2018107246A1 (en) * | 2016-12-16 | 2018-06-21 | The Australian National University | Improving selective internal radiation therapy |
| US10992078B2 (en) | 2018-01-29 | 2021-04-27 | Bard Access Systems, Inc. | Connection system for establishing an electrical connection through a drape and methods thereof |
| EP3793464A4 (en) | 2018-05-18 | 2021-07-21 | Bard Access Systems, Inc. | CONNECTION SYSTEM AND METHOD FOR MAKING AN ELECTRICAL CONNECTION THROUGH A COVERING CLOTH |
| US11622675B2 (en) | 2019-05-15 | 2023-04-11 | Boston Scientific Scimed, Inc. | Medical device having asymmetric bending |
| WO2021011411A1 (en) | 2019-07-12 | 2021-01-21 | Bard Access Systems, Inc. | Catheter tracking and placement system including light emitting diode array |
| WO2021026502A1 (en) | 2019-08-08 | 2021-02-11 | Bard Access Systems, Inc. | Optical-fiber connector modules including shape-sensing systems and methods thereof |
| EP4355418A1 (en) * | 2021-06-14 | 2024-04-24 | Novocure GmbH | Methods of treating and preventing cancer with alternating electric fields, radioactive particles, and systemic therapy |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4789501A (en) | 1984-11-19 | 1988-12-06 | The Curators Of The University Of Missouri | Glass microspheres |
| US6296831B1 (en) | 1998-04-10 | 2001-10-02 | Battelle Memorial Institute | Stimulus sensitive gel with radioisotope and methods of making |
| US6379648B1 (en) | 1999-02-01 | 2002-04-30 | The Curators Of The University Of Missouri | Biodegradable glass compositions and methods for radiation therapy |
| AU2636400A (en) | 1999-02-02 | 2000-08-25 | Curators Of The University Of Missouri, The | Process for making ceramic microspheres |
| AUPR098300A0 (en) | 2000-10-25 | 2000-11-16 | Sirtex Medical Limited | Polymer based radionuclide containing microspheres |
| AUPR098200A0 (en) | 2000-10-25 | 2000-11-16 | Sirtex Medical Limited | Production of low density radionuclide containing microspheres |
| AU2003903387A0 (en) | 2003-07-02 | 2003-07-17 | Sirtex Medical Limited | Combination therapy for treatment of neoplasia |
| JP5855568B2 (ja) * | 2009-09-15 | 2016-02-09 | セルリアン・ファーマ・インコーポレイテッド | 癌の治療法 |
-
2015
- 2015-01-23 CA CA2937015A patent/CA2937015C/en active Active
- 2015-01-23 EP EP15740607.5A patent/EP3096752A4/en active Pending
- 2015-01-23 CN CN201580015101.9A patent/CN106102735A/zh active Pending
- 2015-01-23 SG SG11201605900VA patent/SG11201605900VA/en unknown
- 2015-01-23 JP JP2016548186A patent/JP2017503846A/ja active Pending
- 2015-01-23 US US15/114,058 patent/US10849900B2/en active Active
- 2015-01-23 AU AU2015208666A patent/AU2015208666B2/en active Active
- 2015-01-23 KR KR1020167021641A patent/KR102317751B1/ko active Active
- 2015-01-23 WO PCT/AU2015/000037 patent/WO2015109367A1/en not_active Ceased
- 2015-01-23 BR BR112016016932A patent/BR112016016932A8/pt not_active Application Discontinuation
-
2016
- 2016-07-15 PH PH12016501407A patent/PH12016501407A1/en unknown
- 2016-07-21 IL IL246880A patent/IL246880B/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2017503846A5 (enExample) | ||
| JP2017226708A5 (enExample) | ||
| JP2024015120A5 (enExample) | ||
| JP2016530280A5 (enExample) | ||
| JP2012082215A5 (enExample) | ||
| JP2012506448A5 (enExample) | ||
| JP2016528162A5 (enExample) | ||
| JP2021510725A5 (enExample) | ||
| JP2018511625A5 (enExample) | ||
| JP2020523356A5 (enExample) | ||
| JP2017513809A5 (enExample) | ||
| JP2018507243A5 (enExample) | ||
| JP2016515586A5 (enExample) | ||
| RU2017134443A (ru) | Способ лечения с применением традипитанта | |
| JP2016526531A5 (enExample) | ||
| JPWO2020111018A5 (enExample) | ||
| JP2017516802A5 (enExample) | ||
| JP2020523359A5 (enExample) | ||
| JP2020516646A5 (enExample) | ||
| IL320452A (en) | Combination therapy for prostate cancer | |
| JP2019038796A5 (enExample) | ||
| RU2020134307A (ru) | Режимы дозирования мелфлуфена для раковых заболеваний | |
| JP2018522028A5 (enExample) | ||
| JP2019526559A5 (enExample) | ||
| Librodo et al. | Chronotherapeutic drug delivery |